Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Russian vaccines against especially dangerous bacterial pathogens.

Feodorova VA, Sayapina LV, Corbel MJ, Motin VL.

Emerg Microbes Infect. 2014 Dec;3(12):e86. doi: 10.1038/emi.2014.82. Epub 2014 Dec 17. Review.

2.

Benefits of a European project on diagnostics of highly pathogenic agents and assessment of potential "dual use" issues.

Grunow R, Ippolito G, Jacob D, Sauer U, Rohleder A, Di Caro A, Iacovino R.

Front Public Health. 2014 Nov 11;2:199. doi: 10.3389/fpubh.2014.00199. eCollection 2014. Review.

3.

Glanders: an overview of infection in humans.

Van Zandt KE, Greer MT, Gelhaus HC.

Orphanet J Rare Dis. 2013 Sep 3;8:131. doi: 10.1186/1750-1172-8-131. Review.

4.

PCR-based Methodologies Used to Detect and Differentiate the Burkholderia pseudomallei complex: B. pseudomallei, B. mallei, and B. thailandensis.

Lowe W, March JK, Bunnell AJ, O'Neill KL, Robison RA.

Curr Issues Mol Biol. 2014;16:23-54. Epub 2013 Aug 22. Review.

5.

Development of Burkholderia mallei and pseudomallei vaccines.

Silva EB, Dow SW.

Front Cell Infect Microbiol. 2013 Mar 11;3:10. doi: 10.3389/fcimb.2013.00010. eCollection 2013. Review.

6.

Burkholderia vaccines: are we moving forward?

Choh LC, Ong GH, Vellasamy KM, Kalaiselvam K, Kang WT, Al-Maleki AR, Mariappan V, Vadivelu J.

Front Cell Infect Microbiol. 2013 Feb 5;3:5. doi: 10.3389/fcimb.2013.00005. eCollection 2013. Review.

7.

Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010.

Lipsitz R, Garges S, Aurigemma R, Baccam P, Blaney DD, Cheng AC, Currie BJ, Dance D, Gee JE, Larsen J, Limmathurotsakul D, Morrow MG, Norton R, O'Mara E, Peacock SJ, Pesik N, Rogers LP, Schweizer HP, Steinmetz I, Tan G, Tan P, Wiersinga WJ, Wuthiekanun V, Smith TL.

Emerg Infect Dis. 2012 Dec;18(12):e2. doi: 10.3201/eid1812.120638.

Supplemental Content

Loading ...
Support Center